钆塞酸增强MRI诊断肝细胞癌:韩国腹部放射学会2016年共识建议
韩国腹部放射学会肝病研究组采用改良德尔菲法制定钆塞酸增强MRI诊断肝细胞癌的专家共识建议,在第39届学术大会暨2016年年会上16条陈述中有12条达成共识,旨在促进诊断标准化。
要点
- 韩国腹部放射学会2016年共识针对钆塞酸增强MRI诊断肝细胞癌提出建议。
- 采用改良德尔菲法,16条陈述中12条达成共识。
- 共识旨在确保钆塞酸增强MRI诊断肝细胞癌更加标准化。
核心结论
- 韩国腹部放射学会肝病研究组针对钆塞酸增强MRI诊断肝细胞癌制定专家共识建议,16条陈述中12条达成共识,可能有助于诊断标准化。
研究设计与样本
- 韩国腹部放射学会肝病研究组采用改良德尔菲法制定的专家共识建议,于2016年第39届学术大会暨年会上达成共识。
诊断标准与关键数值
- 共识涉及16条陈述,其中12条达成共识。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Diagnosis of hepatocellular carcinoma (HCC) with gadoxetic acid-enhanced liver magnetic resonance imaging (MRI) poses certain unique challenges beyond the scope of current guidelines. The regional heterogeneity of HCC in demographic characteristics, prevalence, surveillance, and socioeconomic status necessitates different treatment approaches, leading to variations in survival outcomes. Considering the medical practices in Korea, the Korean Society of Abdominal Radiology (KSAR) study group for liver diseases has developed expert consensus recommendations for diagnosis of HCC by gadoxetic acid-enhanced MRI with updated perspectives, using a modified Delphi method. During the 39th Scientific Assembly and Annual Meeting of KSAR (2016), consensus was reached on 12 of 16 statements. These recommendations might serve to ensure a more standardized diagnosis of HCC by gadoxetic acid-enhanced MRI.
引用
- Diagnosis of Hepatocellular Carcinoma with Gadoxetic Acid-Enhanced MRI: 2016 Consensus Recommendations of the Korean Society of Abdominal Radiology. Korean J Radiol. 2017. PMID: 28458595. doi:10.3348/kjr.2017.18.3.427
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。